North Carolina CDMO

North Carolina CDMO

featured image of Genentech's $700M NC Facility: 1900 Jobs Coming!

Genentech’s $700M NC Facility: 1900 Jobs Coming!

BIOT

🌟 Genentech invests $700M in Holly Springs, NC! 👷‍♂️ Over 400 manufacturing jobs created, focusing on obesity treatments. 💼 Major growth ahead! 🏗️

featured image of Regeneron and FUJIFILM Ink $3B Manufacturing Deal!

Regeneron and FUJIFILM Ink $3B Manufacturing Deal!

BIOT

Exciting news! 🎉 FUJIFILM Diosynth and Regeneron sign a 10-year, $3+ billion deal to boost U.S. biologic medicine production! 🏭💼

featured image of Big Pharma Deal: Cyprumed and MSD Team Up!

Big Pharma Deal: Cyprumed and MSD Team Up!

BIOT

🌟 Exciting news! Cyprumed & MSD team up for oral peptide formulations, while Meribel Pharma Solutions launches as a new CDMO! 💊💰

featured image of Unlocking mRNA Success Through Strategic Partnerships

Unlocking mRNA Success Through Strategic Partnerships

BIOT

Unlock mRNA vaccine success! 🌟 Explore manufacturing challenges, quality analytics, and innovative partnerships with experienced CDMOs for optimal results. 🤝🔬📈

featured image of Scinai Launches US Subsidiary to Boost Biotech

Scinai Launches US Subsidiary to Boost Biotech

BIOT

**Excerpt:** 🌟 Scinai Immunotherapeutics launches Scinai Bioservices in Delaware! 🚀 Enhancing CDMO services and collaborating with Serpin Pharma. 💼🔥

featured image of Amgen's $15B Bet on NC: New Plant!

Amgen’s $15B Bet on NC: New Plant!

BIOT

Amgen invests $1.5B in NC for a new plant! 🌟 370 jobs created 💰, supported by a $4.9M grant! 📈🌍

featured image of Powerful Pharma Partnership Boosts US Manufacturing!

Powerful Pharma Partnership Boosts US Manufacturing!

BIOT

🌟 Recipharm and Exela Pharma join forces! 🏭 This alliance boosts sterile manufacturing in the U.S. 💉 Exciting biopharmaceuticals ahead! 📈🤝

featured image of Unlocking Biotech: Why CDMOs Must Embrace Innovation!

Unlocking Biotech: Why CDMOs Must Embrace Innovation!

BIOT

🌍 CDMOs must showcase new bioprocessing tech benefits to win over clients. 💰 Larger firms hesitate, while smaller ones embrace innovation. 🤝

featured image of 2024's Top CDMOs: Leaders and Challenges Ahead!

2024’s Top CDMOs: Leaders and Challenges Ahead!

BIOT

**Excerpt:** Discover the top 10 CDMOs for 2024! 🌟 Lonza, Thermo Fisher, and Catalent lead the way amidst industry challenges. 📈⚠️

featured image of Agilent's $925M Biovectra Buy: Boosting Growth!

Agilent’s $925M Biovectra Buy: Boosting Growth!

BIOT

Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦